DexCom company profile

DXCM · NASDAQ · USD

Compare DexCom
$82.17Change from previous close: −1.39%Absolute change: −$1.16

Close · November 16, 2026

Company profile

DexCom has 11,000 employees and is headquartered in San Diego, United States.

Its core activity is the design, development and sale of continuous glucose monitoring devices for people with diabetes and for metabolic health management. The range includes the Dexcom G7 and G7 15 Day integrated sensor, the Dexcom G6 system, and the Dexcom ONE+, which is intended to replace fingerstick testing in treatment decisions. The company also offers Stelo, a biosensor for adults with prediabetes or Type 2 diabetes who do not use insulin, together with Dexcom Share for remote monitoring and the Dexcom Follow app. Products are marketed directly to endocrinologists, physicians and diabetes educators in the United States and abroad.

In the fiscal year ended December 2025, DexCom reported revenue of 4.7 billion US dollars, up 15.6% from the previous year, and net income of 836.3 million US dollars. The United States accounted for 71.5% of revenue and non-US markets for 28.5%. The company had 11,000 employees, is headquartered in San Diego, California, and was incorporated in 1999.

Company facts

Industry
Medical Devices
Headquarters
6340 Sequence Drive, 92121, San Diego
Employees
11,000
Chief executive
Jacob Leach
Founded
1999
Fiscal year
January - December
Listing
DXCM · NASDAQ
Currency
USD
ISIN
US2521311074
Website
dexcom.com

DexCom and its competitors

The most similar companies by business and size

CompanyCountryMarket capEmployeesOperating marginP/E (trailing 12 months)
DexComDXCMUnited States$31.08B11,00024.0%32.8
GE HealthCare TechnologiesGEHCUnited States$37.8B54,00013.8%17.7
SterisSTEUnited States$25.67B17,93719.2%31.4
Zimmer Biomet HoldingsZBHUnited States$19.53B17,00016.7%26.1
Edwards LifesciencesEWUnited States$61.61B16,00028.8%61.6
Boston ScientificBSXUnited States$64.27B59,00019.6%18.7

Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.

Compare DexCom with its competitors